Meredythe Anne Scheflen

Meredythe Anne Scheflen, career missionary to Bolivia with World Gospel Mission (WGM), was the hostess for the CILA seminar team to the Bolivian Evangelical University (UEB). Here is more about this remarkable lady

Fingernail Injuries and NASA's Integrated Medical Model

The goal of space medicine is to optimize both crew health and performance. Currently, expert opinion is primarily relied upon for decision-making regarding medical equipment and supplies flown in space. Evidence-based decisions are preferred due to mass and volume limitations and the expense of space flight. The Integrated Medical Model (IMM) is an attempt to move us in that direction

Solution Set for TopCoder Dataset

No abstract availabl

Medical Updates Number 5 to the International Space Station Probability Risk Assessment (PRA) Model Using the Integrated Medical Model

The Integrated Medical Model (IMM) Project has been developing a probabilistic risk assessment tool, the IMM, to help evaluate in-flight crew health needs and impacts to the mission due to medical events. This package is a follow-up to a data package provided in June 2009. The IMM currently represents 83 medical conditions and associated ISS resources required to mitigate medical events. IMM end state forecasts relevant to the ISS PRA model include evacuation (EVAC) and loss of crew life (LOCL). The current version of the IMM provides the basis for the operational version of IMM expected in the January 2011 timeframe. The objectives of this data package are: 1. To provide a preliminary understanding of medical risk data used to update the ISS PRA Model. The IMM has had limited validation and an initial characterization of maturity has been completed using NASA STD 7009 Standard for Models and Simulation. The IMM has been internally validated by IMM personnel but has not been validated by an independent body external to the IMM Project. 2. To support a continued dialogue between the ISS PRA and IMM teams. To ensure accurate data interpretation, and that IMM output format and content meets the needs of the ISS Risk Management Office and ISS PRA Model, periodic discussions are anticipated between the risk teams. 3. To help assess the differences between the current ISS PRA and IMM medical risk forecasts of EVAC and LOCL. Follow-on activities are anticipated based on the differences between the current ISS PRA medical risk data and the latest medical risk data produced by IMM

Medical Updates to the International Space Station Probabilistic Risk Assessment Model Using the Integrated Medical Model

No abstract availabl

Report of NSF Workshop Series on Scientific Software Security Innovation Institute

Many individuals attended these workshops and contributed to the writing of this report. They are named in the report itself.Over the period of 2010‐2011, a series of two workshops were held in response to NSF Dear Colleague Letter NSF 10‐050 calling for exploratory workshops to consider requirements for Scientific Software Innovation Institutes (S2I2s). The specific topic of the workshop series was the potential benefits of a security-­‐focused software institute that would serve the entire NSF research and development community. The first workshop was held on August 6th, 2010 in Arlington, VA and represented an initial exploration of the topic. The second workshop was held on October 26th, 2011 in Chicago, IL and its goals were to 1) Extend our understanding of relevant needs of MREFC and large NSF Projects, 2) refine outcome from first workshop with broader community input, and 3) vet concepts for a trusted cyberinfrastructure institute. This report summarizes the findings of these workshops.This material is based upon work supported by the National Science Foundation under grant number 1043843. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science

Helicobacter pylori phagosome maturation in primary human macrophages

Extent: 14p.Background: Helicobacter pylori (H. pylori) is a micro-aerophilic, spiral-shaped, motile bacterium that is the principal cause of gastric and duodenal ulcers in humans and is a major risk factor for the development of gastric cancer. Despite provoking a strong innate and adaptive immune response in the host, H. pylori persists in the gastric mucosa, avoiding eradication by macrophages and other phagocytic cells, which are recruited to the site of infection. Here we have characterised the critical degradative process of phagosome maturation in primary human macrophages for five genotypically and phenotypically distinct clinical strains of H. pylori. Results: All of the H. pylori strains examined showed some disruption to the phagosome maturation process, when compared to control E. coli. The early endosome marker EEA1 and late endosome marker Rab7 were retained on H. pylori phagosomes, while the late endosome-lysosome markers CD63, LAMP-1 and LAMP-2 were acquired in an apparently normal manner. Acquisition of EEA1 by H. pylori phagosomes appeared to occur by two distinct, strain specific modes. H. pylori strains that were negative for the cancer associated virulence factor CagA were detected in phagosomes that recruited large amounts of EEA1 relative to Rab5, compared to CagA positive strains. There were also strain specific differences in the timing of Rab7 acquisition which correlated with differences in the rate of intracellular trafficking of phagosomes and the timing of megasome formation. Megasomes were observed for all of the H. pylori strains examined. Conclusions: H. pylori appeared to disrupt the normal process of phagosome maturation in primary human macrophages, appearing to block endosome fission. This resulted in the formation of a hybrid phagosome-endosome-lysosome compartment, which we propose has reduced degradative capacity. Reduced killing by phagocytes is consistent with the persistence of H. pylori in the host, and would contribute to the chronic stimulation of the inflammatory immune response, which underlies H. pylori-associated disease.Glenn N Borlace, Hilary F Jones, Stacey J Keep, Ross N Butler, Doug A Brook

The Grizzly, February 24, 1984

Bio Requirements to be Revised • Best to Perform at Music Forum • Contemporary Plays for proTheatre • Scholarship Competition Opens • Wellness Includes Mind, Body and Spirit • For the Record.. Selling Sex • MacLaine and Winger Come to Terms • Come to the Cabaret • Visit Barnes for Real Art • Aquabears Headed for MACshttps://digitalcommons.ursinus.edu/grizzlynews/1113/thumbnail.jp

Light hadron spectrum---MILC results with the Kogut-Susskind and Wilson actions

We present the current status of our ongoing calculations of the light hadron spectrum with both Kogut-Susskind (KS) and Wilson quarks in the valence or quenched approximation. We discuss KS quarks first and find that the chiral extrapolation is potentially the biggest source of systematic error. For the Wilson case, we focus on finite volume and source size effects at 6/g^2=5.7. We find no evidence to support the claim that there is a finite volume effect between N_s=16 and 24 of approximately 5%.Comment: 11 pages, 11 figures, LaTeX, uses espcrs2, epsf, Invited talk presented by S. Gottlieb at Lattice QCD on Parallel Computers, University of Tsukuba, March, 1997, to appear in the proceeding